## Filings that contain financial statements

- **8-K filed August 26, 2026 (accession 0001193125-26-368620), Exhibit 99.1** — third-quarter fiscal 2026 results (quarter ended July 31, 2026): GAAP and non-GAAP income statement reconciliations, segment commentary, and fourth-quarter/full-year FY26 financial targets.
- **10-Q filed August 26, 2026 (accession 0000883241-26-000025)** — full condensed consolidated financial statements (income statement, balance sheet, cash flows) for the quarter and nine months ended July 31, 2026, including the Ansys purchase-price-allocation note.
- **8-K filed May 27, 2026 (accession 0001193125-26-241911), Exhibit 99.1** — second-quarter fiscal 2026 results (quarter ended April 30, 2026).
- **8-K filed February 25, 2026 (accession 0001193125-26-071601), Exhibit 99.1** — first-quarter fiscal 2026 results (quarter ended January 31, 2026).
- **8-K filed December 10, 2025 (accession 0001193125-25-314200), Exhibit 99.1** — fourth-quarter and full fiscal-year 2025 results (year ended October 31, 2025).
- **10-K filed December 22, 2025 (accession 0000883241-25-000028)** — full audited consolidated financial statements for fiscal year 2025, including the Ansys business-combination note.
- **8-K filed September 9, 2025 (accession 0001193125-25-199178), Exhibit 99.1** — third-quarter fiscal 2025 results (quarter ended July 31, 2025), the first quarter to include Ansys results following the acquisition close.

## Ansys acquisition — closed

On July 17, 2025, Synopsys completed its acquisition of ANSYS, Inc., a provider of engineering simulation and analysis software, pursuant to the Agreement and Plan of Merger dated January 15, 2024. Total consideration was approximately $34.9 billion, consisting of $199.91 in cash and 0.3399 of a Synopsys share for each Ansys share (roughly $17.6 billion in cash and $17.1 billion in stock, plus the fair value of assumed equity awards). Synopsys funded the cash portion with cash on hand, proceeds from newly issued Senior Notes, and $4.3 billion drawn under a new term loan, bringing total debt to approximately $13.5 billion as of October 31, 2025. Ansys results have been included in Synopsys' consolidated financial statements since the acquisition date. (Source: Form 10-K filed December 22, 2025, accession 0000883241-25-000028; Form 10-Q filed August 26, 2026, accession 0000883241-26-000025.)

## Divestitures

- **October 17, 2025** — Synopsys completed the "Regulatory Divestitures" required as a condition of the Ansys Merger: the sale of its Optical Solutions Group (OSG) to Keysight Technologies, Inc., together with Ansys' PowerArtist RTL business, also sold to Keysight. Combined cash consideration was $604.0 million; Synopsys disposed of $55.1 million of net assets (including $19.5 million of goodwill) and recognized a pre-tax gain on sale of $548.9 million, or $516.3 million net of $32.6 million of divestiture-related expenses, recorded in other income (expense), net. The divestitures were not presented as discontinued operations. (Source: Form 10-K filed December 22, 2025, accession 0000883241-25-000028; no separate 8-K covers this event in the filings reviewed here.)
- **June 1, 2026** — Synopsys completed the sale of its Processor IP Solutions (Processor IP) business, part of the Design IP segment, to GlobalFoundries Inc., as part of a reallocation of resources to the highest-growth opportunities within Design IP. Total cash consideration was $443.3 million ($440.0 million net proceeds). Synopsys derecognized $17.9 million of net assets (including $38.0 million of goodwill) and recognized a pre-tax gain on sale of $425.4 million, or $380.5 million net of $44.9 million of divestiture-related expenses, recorded in other income (expense), net. The divestiture was not presented as discontinued operations, as it did not represent a strategic shift with a major effect on the business and was not material to the business for that purpose. This gain is the largest single item affecting the third-quarter fiscal 2026 income statement. (Source: Form 10-Q filed August 26, 2026, accession 0000883241-26-000025; no 8-K covering this event is among the filings reviewed here.)

## Quarterly earnings

- **September 9, 2025** — Synopsys reported third-quarter fiscal 2025 results: revenue of $1.740 billion, up 14% year-over-year; GAAP EPS of $1.50; non-GAAP EPS of $3.39. Results marked the first quarter reflecting the July 17, 2025 close of the Ansys acquisition. Full-year fiscal 2025 revenue was guided to $7.03–$7.06 billion. (8-K, accession 0001193125-25-199178.)
- **December 10, 2025** — Fourth-quarter and full fiscal-year 2025 results: record full-year revenue of $7.054 billion, up approximately 15%; fourth-quarter revenue of $2.255 billion, with Ansys contributing $667.7 million in the quarter and $756.6 million for the full year. GAAP EPS for the year was $8.07; non-GAAP EPS was $12.91. Fiscal 2026 revenue was guided to $9.610 billion at the midpoint, including approximately $2.9 billion of expected Ansys revenue. (8-K, accession 0001193125-25-314200.)
- **February 25, 2026** — First-quarter fiscal 2026 results: revenue of $2.409 billion, at the high end of prior guidance; GAAP EPS of $0.34; non-GAAP EPS of $3.77, above guidance. Full-year revenue guidance was reiterated at $9.61 billion at the midpoint. The board also approved a $2.0 billion replenishment of the stock repurchase program (see Capital actions below). (8-K, accession 0001193125-26-071601.)
- **May 27, 2026** — Second-quarter fiscal 2026 results: revenue of $2.276 billion, above prior guidance; GAAP EPS of $0.09; non-GAAP EPS of $3.35. Full-year revenue guidance was raised to $9.665 billion at the midpoint and non-GAAP EPS guidance raised to $14.76 at the midpoint. Synopsys also announced plans to hold an Investor Day on September 30, 2026. (8-K, accession 0001193125-26-241911.)
- **August 26, 2026** — Third-quarter fiscal 2026 results: revenue of $2.477 billion, exceeding the high end of guidance; GAAP EPS of $2.84; non-GAAP EPS of $3.91, also above guidance. Full-year revenue guidance was raised to $9.715 billion at the midpoint and non-GAAP EPS guidance raised to $15.07 at the midpoint, citing continued AI-driven demand. Management noted broad-based strength led by EDA, a strong Ansys quarter, and a return to year-over-year growth in Design IP. (8-K, accession 0001193125-26-368620.)

## Restructuring

- **November 9, 2025** — Synopsys' board approved a restructuring plan expected to result in the termination of approximately 10% of the workforce as of fiscal 2025 year-end, intended to support investment in growth opportunities and drive efficiencies following the Ansys acquisition. The company initially estimated pre-tax GAAP charges of $300–$350 million, with a majority of workforce reductions expected in fiscal 2026 and substantial completion by the end of fiscal 2027. (8-K filed November 12, 2025, accession 0001193125-25-276232.)
- **August 26, 2026** — Synopsys filed a Form 8-K/A amending the November 2025 restructuring disclosure. On August 21, 2026, the board approved updated cost estimates, raising the expected pre-tax GAAP charge range to $425–$500 million from the original $300–$350 million, reflecting additional severance, termination benefits, and site-closure costs. (8-K/A, accession 0001193125-26-368858 — this amendment carries a "date of earliest event reported" of November 9, 2025 because it amends and restates the cost estimate in the original November 2025 8-K; it was filed August 26, 2026.)

## Capital actions

- **February 25, 2026** — Synopsys' board approved a replenishment of the existing stock repurchase program, authorizing purchases of up to $2.0 billion of common stock. (8-K, accession 0001193125-26-071601.)
- **March 2, 2026** — Synopsys entered into a $250 million accelerated share repurchase agreement with The Bank of Nova Scotia, with an initial share delivery of approximately 513,000 shares and final settlement expected on or before June 1, 2026. (8-K, accession 0001193125-26-084396.)
- **December 1, 2025** — Synopsys entered into a Securities Purchase Agreement with NVIDIA Corporation under which NVIDIA purchased 4,821,717 shares of Synopsys common stock at $414.79 per share, for an aggregate $2 billion private placement. The transaction accompanied a joint announcement of an expanded, multi-year strategic partnership spanning NVIDIA CUDA-accelerated computing, agentic and physical AI, and Omniverse digital twins to accelerate Synopsys' engineering and simulation software. (8-K, accession 0001193125-25-303209.)

Note: Synopsys' stock repurchase program had been suspended in connection with the Ansys Merger, per the fiscal 2025 Form 10-K, to allow debt levels to be reduced following the acquisition financing; the February and March 2026 repurchase actions above represent renewed capital return activity.

## Board and management changes

- **September 17, 2025** — The board appointed Ravi Vijayaraghavan, who had joined the board on July 17, 2025 in connection with the Ansys Merger closing, as a member of the Corporate Governance and Nominating Committee. (8-K/A, accession 0001193125-25-207472, filed September 18, 2025, amending the original Form 8-K filed July 17, 2025 to add this committee-appointment disclosure.)
- **November 4, 2025** — Rick Mahoney ceased serving as Chief Revenue Officer, effective immediately; Synopsys said it was in advanced stages of searching for a replacement. (8-K, accession 0001193125-25-263692.)
- **February 14, 2026** — The board expanded from eleven to twelve directors and appointed Peter A. Shimer, a former senior Deloitte executive (including interim CEO), to the board and its Audit Committee. Synopsys also announced that directors Luis Borgen and Dr. Ajei Gopal would not be renominated for election at the 2026 Annual Meeting, though both continued to serve through that meeting. (8-K, accession 0001193125-26-059438.)
- **April 16, 2026** — At its 2026 Annual Meeting, Synopsys stockholders elected ten directors, approved the company's Amended and Restated Equity Incentive Plan (extending eligibility to non-employee directors), approved executive compensation on an advisory basis, and ratified KPMG LLP as independent auditor for fiscal year ending October 31, 2026. A stockholder proposal on the right to act by written consent was not approved. (8-K, accession 0001193125-26-164085.)
- **May 26, 2026** — Synopsys entered into a Cooperation Agreement with Elliott Investment Management L.P. and affiliated funds ("Elliott"). Under the agreement, the board was expanded by one seat and Jesse Cohn, an Elliott Managing Partner, was appointed as an independent director effective June 1, 2026, also joining the Corporate Governance and Nominating Committee, with an initial term through the 2027 Annual Meeting. The agreement includes customary standstill terms (Elliott capped at 4.9% beneficial ownership / 7.5% economic exposure during the cooperation period), voting commitments, and non-disparagement provisions, generally running for one year from signing or ten days after Cohn (or a replacement director) leaves the board, whichever is later. (8-K, accession 0001193125-26-241920.)
- **August 12, 2026** — Synopsys announced that Janet Lee will step down as General Counsel and Corporate Secretary, effective the earlier of December 31, 2026 or the appointment of her successor, after which she will remain in an advisory role through June 30, 2027 (or later, at the company's discretion) to support the transition. (8-K, accession 0001193125-26-345878.)

## Not among the filings reviewed here

The original Form 8-K reporting the July 17, 2025 closing of the Ansys acquisition was not itself among the filings reviewed for this events file. Its existence and contents are evidenced by the Form 8-K/A (accession 0001193125-25-207472, filed September 18, 2025) reviewed above, which states that it "amends the current report on Form 8-K filed by Synopsys, Inc. ... on July 17, 2025." Separately, the acquisition's terms and closing date are also confirmed by Synopsys' fiscal 2025 Form 10-K and its fiscal 2026 third-quarter Form 10-Q, both of which describe the transaction as completed and include Ansys in the consolidated financial statements from the acquisition date forward.